Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 5051 (2025-2026)

https://ontology.bommaritollc.com/id/01a0d569-bdbb-75bb-b685-09ef1670841b

adms:identifier	mi-legislature-measure 2025-2026/HB/5051
dcterms:temporal	Michigan Legislature, 2025-2026 session
primary sponsor	Nancy DeBoer
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-5051
schema:legislationChanges	2020 PA 312
schema:legislationIdentifier	HB 5051
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; administration of epinephrine; modify. Amends title & secs. 1, 2 & 3 of 2020 PA 312 (MCL 28.821 et seq.). TIE BAR WITH: HB 5054'25 , HB 5049'25 , HB 5050'25 , HB 5052'25 , HB 5053'25en
schema:sponsor	Regina Weiss Mai Xiong Jason M Hoskins Morgan Foreman Nancy Jenkins-Arno Steve Frisbie Kathy Schmaltz Brenda Carter Mark A Tisdel Thomas Kuhn Alicia St. Germaine Joseph Pavlov Brian BeGole Penelope Tsernoglou Nancy DeBoer Will Snyder Luke Meerman Matthew Bierlein David Prestin Karl Bohnak
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-5051
skos:prefLabel	HB 5051 (2025-2026)en